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Abstract: Three myxobacterial strains, designated SWB004, SWB005 and SWB006, were 
obtained from beach sand samples from the Pacific Ocean and the North Sea. The strains 
were cultivated in salt water containing media and subjected to studies to determine their 
taxonomic status, the presence of genes for the biosynthesis of polyketides and antibiotic 
production. 16S rDNA sequence analysis revealed the type strain Enhygromyxa salina 
SHK-1
T as their closest homolog, displaying between 98% (SWB005) and 99% (SWB004 
and SWB006) sequence similarity. All isolates were rod-shaped cells showing gliding 
motility and fruiting body formation as is known for myxobacteria. They required NaCl for 
growth, with an optimum concentration of around 2% [w/v]. The G + C-content of 
genomic DNA ranged from 63.0 to 67.3 mol%. Further, the strains were analyzed for their 
potential to produce polyketide-type structures. PCR amplified ketosynthase-like gene 
fragments from all three isolates enhances the assumption that these bacteria produce 
polyketides. SWB005 was shown to produce metabolites with prominent antibacterial 
activity, including activity towards methicillin resistant Staphylococcus aureus (MRSA) 
and Staphylococcus epidermidis (MRSE). 
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1. Introduction  
Myxobacteria are Gram-negative gliding bacteria with a high G + C content, performing a complex 
series of cellular differentiation processes that lead to fruiting body formation. Phylogenetic studies, 
using 16S rDNA sequences, showed that myxobacteria are located in a homogeneous cluster within 
the δ-Proteobacteria. Most myxobacteria have a heterotrophic life style and the ability to lyse a variety 
of bacteria and fungi to obtain nutrients from lysis products. Terrestrial myxobacteria usually do not 
tolerate NaCl concentrations greater than 1.0%, which is clearly lower than that found in seawater with 
an average of 3.5% NaCl [1]. Although, sporadic reports of myxobacteria from marine environments 
appeared, only a few seemed to indeed be of marine origin. Myxobacterial isolates found in marine 
habitats being nonhalotolerant, are presumed to have arisen from myxospores of terrestrial 
myxobacteria which germinated under laboratory conditions. It is assumed that such spores have been 
transferred from the land to seawater and beach areas, thus being found in samples taken from the 
marine environment [2,3]. In recent times, several halophilic myxobacteria have been described and 
classified as novel myxobacterial genera, namely Haliangium, Plesiocystis and Enhygromyxa [4–6]. 
A striking characteristic of myxobacteria is their ability to produce structurally intriguing natural 
products with prominent biological activities, i.e., 17 secondary metabolite loci are encoded in the 
genome of the model myxobacterium Sorangium cellulosum [7]. As the majority of these metabolites 
are polyketides, nonribosomal polypeptides, or a hybrid of both [8,9], the number of polyketide 
synthases (PKSs) found in these organisms is extremely high. Several myxobacterial natural products 
have antibiotic activity, e.g., etnangien and corallopyronin A. The first one, a macrolide antibiotic, was 
isolated from Sorangium cellulosum and its biosynthetic gene cluster was analyzed, revealing an 
unusual polyketide biosynthesis [10,11]. The latter was isolated from Corallococcus coralloides and is 
synthesized by a mixed PKS/nonribosomal peptide synthetase (NRPS)-system [12,13]. These 
organisms may use their secondary metabolites to weaken or kill their prey, a suggestion which could 
explain why many of them are excellent producers of bioactive secondary metabolites.  
All of these features make myxobacteria an excellent source of hitherto unknown novel compounds. 
Terrestrial myxobacteria have been extensively investigated for their metabolite production [14]. The 
epothilone derivative ixabepilone is used in cancer therapy and demonstrates the potential of 
myxobacterial secondary metabolism [15]. Myxobacteria from unusual ecological niches, for example 
the marine environment, are hardly ever investigated due to the fact that their isolation and cultivation 
is difficult. Problems include their slow growth with the consequence that they are easily overgrown 
by other organisms during the isolation procedure; additionally they cannot be cultivated in rich media 
which results in poor cell density. 
The aim of the current study is to find microorganisms which can tolerate the marine ecological 
pressures, e.g., the salt concentration, and to explore their potential to produce bioactive compounds, 
especially antibiotics. This study focuses on three strains of the taxon Enhygromyxa salina which we 
isolated and cultivated from coastal sand samples. The taxonomy was determined by 16S rDNA Mar. Drugs 2010, 8  
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analysis. Cultivation experiments proved that the bacteria are physiologically adapted to the marine 
environment, being able to tolerate “ocean-like” NaCl concentrations of 3.5%. All strains harbor PKS 
genes in their genome. To date however, only strain SWB005 was shown to produce metabolites with 
prominent antibacterial activity, including activity towards methicillin resistant Staphylococcus aureus 
(MRSA) and Staphylococcus epidermidis (MRSE). 
2. Results and Discussion  
2.1. Morphological characterization 
During the current study, three bacterial strains (SWB004, SWB005 and SWB006) were obtained, 
which we were able to grow in liquid and on solid media. The vegetative cells of all three marine 
isolates are rod shaped with blunt rounded ends, measuring 1.2–2.6 µm in length and 0.3–0.4 µm in 
width when grown on agar plates (Figure 1).  
Figure 1. Phase-contrast micrograph of vegetative cells of the three Enhygromyxa salina 
strains cultured on VY¼ agar plates: (a) SWB006; (b) SWB005; (c) SWB004.   
(Bar = 10 µm).  
 
All showed gliding motility and the swarms appeared as shallow sunken craters on the plates. The 
agar surface was sometimes shallowly etched by all three strains. The swarming colonies were 
colorless and formed a thin film on VY¼ agar. There were however, also some minor differences 
concerning the appearance of the swarming colonies of the three bacterial isolates. Thus, SWB006 was 
the only strain that sometimes showed deep sunken craters on the agar plates. Swarms of SWB006 and 
SWB004 were able to reach the rim of the plastic dish after several weeks of incubation, SWB005 
however, never swarmed that far and stopped its gliding mobility after 2 cm. Radial patterns were 
sometimes formed by the swarms. Orange colored fruiting bodies, globular to polyhedral in shape, 
appeared on the surface of the swarming colonies after approximately two weeks cultivation on VY¼ 
agar and were barely visible without magnification. When they were crushed, spherical cells,   
0.3–0.6  µm in diameter, became visible under the light microscope. In liquid culture all bacterial 
isolates formed cell clumps in an orange to reddish-orange shade of color. Disperse growth in liquid Mar. Drugs 2010, 8  
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media was not observed. From their morphological appearance it could be concluded that these 
bacteria belong to the Myxobacteriaceae. 
2.2. Physiological Characterization 
The phenotypic features of all three strains, along with those of the reference strain 
Enhygromyxa salina DSM 15201 are summarized in Table 1. The isolates were aerobic and able to 
grow on VY¼ and (very poorly on) CY⅓ agar, with SWB006 and SWB004 preferring the ionic 
composition of SWS, while SWB005 preferred ASW as artificial seawater (experimental section). All 
strains lysed living Bacillus megaterium, Escherichia coli, Pseudomonas spec., and Vibrio fischeri 
cells (Figure 2). Autoclaved yeast cells were only lysed in liquid cultures where clearing of the 
medium was observable. On agar plates, no area of clearance appeared around the colonies, meaning 
that the yeast cells were not decomposed. The strains did not hydrolyze cellulose, chitin, starch and 
tween20. On alginate, no growth at all was visible. Growth occurred at both temperatures, 19 °C and 
30 °C, but not at 37 °C. 
Figure 2. Pictures of a swarming colony on VY¼ solid medium: (a) SWB006, 
(b) SWB005, (c) SWB004. The swarming colonies are colorless. In the middle is the agar 
block used as inoculum. The round structures consist of living bacteria spotted on the agar. 
Clockwise, starting at the right hand side: Bacillus megaterium,  Escherichia coli, the 
mixture of all cells, Pseudomonas spec., Vibrio fischeri. The white arrows indicate the 
border of the swarming cells. It can be seen that the swarms lyse the bacterial prey.  
 
Marine bacteria have been defined as living in marine habitats and requiring sodium for 
growth [16]. Magnesium is often also needed for growth [16]. To test the marine nature of the three 
isolates, the influence of salinity and inorganic salts on their growth was investigated. The optimum 
salt concentration for growth was approximately 2% NaCl, which coincides with that for the reference 
strain DSM 15201. The strains however, showed some differences concerning salt requirements and 
tolerance (Figure 3). SWB006 showed the best growth at 1.5% NaCl and stopped growing at 4% NaCl. 
SWB004 had optimal growth between 1.0 and 2.5% and could tolerate up to 4.5% NaCl. Both of these 
strains were able to grow at low salt concentrations of 0.1% NaCl and at this low salt concentration 
even reached the rim of the agar dish after a long incubation time (4 weeks at 30 °C). SWB005 started 
a c b Mar. Drugs 2010, 8  
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growing at a salt concentration of 0.5% NaCl and was able to tolerate up to 7% NaCl. The optimal salt 
concentration was 2.5% NaCl. It could be hypothesized that this potential to stand higher salt 
concentrations than other Enhygromyxa strains is at the expense of growth rates. Thus, SWB005 
swarms never reached the rim of an agar dish, instead they stopped swarming some centimeters away 
from the inoculum. The requirements concerning inorganic salts, i.e., Ca
2+, K
+, Mg
2+ were tested on 
CY⅓ agar containing 2% NaCl. In each case, the best growth was observed with all ions added to the 
medium. SWB005 and SWB004, however, were also able to grow when only one of these ions was 
supplemented. The strain SWB006 needed the supplementation of Ca
2+ and Mg
2+ for growth. In 
general, physiological differences between the strains exist, but are rather marginal. The bacterial 
isolates described here, possess all characteristic phenotypic features expected for marine 
myxobacteria, such as the requirement for NaCl and other trace elements present in seawater necessary 
for growth. The optimal NaCl concentration is in the range of 1–2.5%, which is characteristic of 
Enhygromyxa spp., but slightly lower than that found for other marine myxobycterial genera like 
Haliangium sp. (1–3%) and Plesiocystis sp. (2–3%)[4,5]. It is likely that this reflects an adaptation to 
seashore environments, where salt concentrations are not stable [6]. So, all three bacterial strains have 
properties expected for marine microorganisms and fall into the category of slightly halophilic 
bacteria [17]. 
Figure 3. NaCl requirements of the three strains. The x-axis marks the NaCl-concentration 
in percent. The intensity of the black bars represents the growth characteristic (darker 
equates to better growth). 
 
Table 1. Phenotypic characteristics of the new isolates compared with E. salina DSM15201. 
  SWB005  SWB006  SWB004  DSM 15201 
Colony color (on VY1/4)  colorless colorless colorless  colorless 
Rod cell 
#:        
Diameter (µm)  ca. 0.35  ca. 0.35  ca. 0.35  0.5–0.8 * 
Length (µm)  1.2–1.8  1.3–2.6  1.2–2.6  1.5–7.0 * 
Myxospore:        
Shape spherical  spherical  spherical  spherical  * 
Diameter (µm)  0.3–0.5  0.3–0.6  0.3–0.6  0.5–0.7 * 
Growth at:         
19 °C  yes  yes  yes  yes * 
30 °C  yes  yes  yes  yes 
37 °C  no  no  no  no * 
0          1          2          3          4          5          6          7 
SWB004 
SWB006 
SWB005 Mar. Drugs 2010, 8  
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Table 1. Cont. 
Growth salinity (%NaCl):        
Range 1.0–7.0  0.1–3.5  0.1–4.0  0.1–4.0  * 
Optimum 1.5–4.5  1.0–2.0  1.0–2.5  1.0–2.0  * 












Oxidase yes  yes  yes  yes 
Catalase yes  yes  yes  yes 
Hydrolysis of:         
Alginate  no growth  no growth  no growth  no 
Cellulose no  no  no  no 
Chitin no  no  no  no 
Starch no  no  no  no 
Tween 20  no  no  no  no growth 
Yeast cells (autoclaved)  weak  yes  yes  yes 
E. coli cells (alive)  yes  yes  yes  yes 
G + C content (mol%)  63.0  67.3  63.7  65–67 * 
Preferred artificial seawater  ASW  SWS  SWS  SWS 
* Data were obtained from Iizuka et al. [6]; 
# The fact that the dimensions of the cells were a little bit smaller 
compared to the original publication can be due to the fact that these results were obtained from cells and 
spores grown on agar plates and not in liquid medium. 
2.3. Chemotaxonomy 
All three bacterial isolates possessed similar fatty acid profiles, which were analyzed by GC-MS. 
E. salina strains were reported to have iso15:0, iso16:0 and iso17:0 as major fatty acids [6]. These 
three branched fatty acids were also the major components in SWB004, SWB005 and SWB006. 
Additionally, polyunsaturated fatty acid 20:4 was detected, whereas hydroxy acids were not found. 
2.4. DNA analysis 
The G + C-content of genomic DNA was determined as 63.0 mol% for SWB005, 63.7 mol% for 
SWB004, and 67.3 mol% for SWB006. This high G + C-content is in the range of the reported values 
(65–67 mol%) for other Enhygromyxa species [6]. The G + C-contents of Enhygromyxa species are 
thus very similar, albeit to some extent lower than those values reported for terrestrial myxobacteria. 
The latter have a G + C-content between 67 and 72 mol% [1]. 
Phylogenetic analyses were performed based on 16S rDNA sequences (sequence information 
obtained by PCR with the primer pair pA/pH, see experimental section). These sequences showed for 
all three strains 98–99% identity to the E. salina strains SHK-1 and SMK1-3 (Figure 4). The 
dendrogram is constructed on the basis of 16S rDNA sequence data of the three isolates SWB004, 
SWB005 and SWB006, together with sequences from representatives of formerly reported marine 
myxobacteria like E. salina, P. pacifica, H. ochraceum and H. tepidum. Included were also sequences 
from uncultured myxobacteria originating from environmental samples, and representing the best hits 
in a BLAST search. The three new isolates SWB004, SWB005 and SWB006 fall into one cluster with 
the two E. salina strains described by Iizuka et al. [6]; together with the isolates PR5 and SYR-2, 
originating from environmental samples, the latter one from brackish water. Our bacterial isolates thus Mar. Drugs 2010, 8  
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broaden the branch of Enhygromyxa species within the tree of the marine myxobacteria considerably. 
The marine myxobacteria Haliangium, Nannocystis and Plesiocystis species are quite distinct from 
Enhygromyxa and each genus forms its own branch. Since only a small number of marine 
myxobacteria were analyzed, the phylogenetic tree in Figure 4 represents a rather preliminary picture 
of the relationship among these bacterial taxa and underlines the necessity to further investigate these 
unusual and difficult to handle bacteria. Included in the databases are, however, uncultured bacterial 
isolates, for which no firm confirmation of their taxonomic status is available. In these cases, it will be 
most important to investigate whether they are indeed part of the ascribed genus or whether they form 
a branch of their own.  
Figure 4. Phylogenetic dendrogram based on the 16S rDNA sequences. The bar specifies 
10 nucleotide substitutions per 100 sites. The accession numbers of the sequences are:  
B 05 87 (EU050860), SYR-2 (AB303310), PR5 (DQ298325), SWB005 (HM769728), 
SWB006 (HM769729), SWB004 (HM769727), SHK-1 (AB097590), SMK1-3 (AB097591), 
DSM14436 (NR_024781), DSM14365 (NR_027522), H. ochraceum (EF108312),   
Na a1 (AJ233945), Na e571 (AJ233947), SHI-1 (AB016469), SIR-1 (NR_024795),   
80T9d (FM242325), WW2 110 (GQ264292), WW2 130 (GQ264310).  






Enhygromyxa salina SHK-1 
Enhygromyxa salina SMK1-3 
Haliangium tepidium DSM14436 
Haliangium ochraceum DSM14365 
Haliangium ochraceum 
Nannocystis aggregans Na a1 
Nannocystis exedens Na e571 
Plesiocystis pacifica SHI-1 
Plesiocystis pacifica SIR-1
uncultured 80 T9d-oil 
uncultured WW2 110 
uncultured WW2 130 
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A noteworthy fact is that when performing a BLAST search with the 16S rDNA sequence from 
SWB006, 37 of the first 50 hits originate from uncultured clones (Table S1). This demonstrates again 
the difficulties in isolating and cultivating these bacteria and the urgent need to optimize isolation and 
cultivation conditions. 
2.5. The ability to produce secondary metabolites with antibacterial activity 
Terrestrial myxobacteria are a rich reservoir for structurally complex secondary metabolites with 
various pharmacological activities. Substances with antibacterial activity being in the centre of recent 
investigations were for example the RNA polymerase inhibitors etnangien, corallopyronin A and 
ripostatin B [11,12,18]. To date, marine myxobacteria, namely Enhygromyxa,  Plesiocystis and 
Haliangium species, were shown to harbor novel PKS genes, and thus have the capability for the 
production of new polyketides [19]. That it is reasonable to expect that marine myxobacteria are an 
excellent source for new bioactive small molecules was shown in 2001 by Fudou et al. [20]. They 
isolated the new antifungal antibiotic haliangicin from the marine myxobacterium Haliangium luteum. 
The activity of this metabolite is based on inhibiting the electron flow within the cytochrome b-c1 
segment, and found to be superior to that of strong inhibitors, such as myxothiazol and cystothiazol. 
The potential of the three strains SWB004, SWB005 and SWB006 for producing secondary 
metabolites was tested in two ways: (i) on the genetic level PKS genes were amplified, sequenced and 
compared with known sequences in the BLAST data base; (ii) the extracts of the strains were tested in 
agar diffusion assays for antimicrobial activity.  
To analyze the sequences generated with degenerate primers for ketosynthase genes the 
amplificates were cloned and subsequently single clones were randomly sequenced (n = 15). For 
SWB004 two, for SWB005 and SWB006, in each case, three different PKS sequences were found, 
respectively. Even though only a small number of clones was sequenced, some sequences arose with 
high frequency, e.g., from the six sequences obtained for SWB004 four times a sequence showing 74% 
identity to a putative gene identified in Frankia alni str. ACN14A showed up, and twice, the highest 
identity (72 and 71%, respectively) was found to a putative ketosynthase gene of 
Polyangium cellulosum  So0157-2-KS1. The highest identity in this screening (88%) was found 
between sequence #1 from SWB005 and a putative PKS gene from Enhygromyxa sp. SYM-1. In a 
recent study investigating the potential of marine bacteria for secondary metabolite biosynthesis, it was 
shown that sequence identities of ≥85% may ascertain which natural product is produced [21]. Taking 
into consideration that the two organisms are closely related, it can be assumed that the same 
compound may be synthesized by these two strains. The latter sequences are only distantly related to 
sequences from known gene clusters, and fall into a marine-specific clade of PKS-sequences [19] for 
which, to our knowledge, no cluster corresponding to a substance has been described so far.  
The sequences found in SWB006, showed between 69 and 73% identity to PKS genes from 
Streptomyces and Actinoplanes species, whereas the high sequence identity between the sequences #1–4 
strongly suggests that they were amplified from the same template (Table 2, Figure S1). Furthermore, 
only very few base substitutions (98% identity) were detectable between the sequences SWB004 #1 
and SWB006 #1, which may indicate that they share the same biosynthetic pathway (Figure S2). Mar. Drugs 2010, 8  
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Table 2. Sequences of the amplified PKS-like fragments of the three Enhygromyxa salina 
strains and their closest homologs. The results of the nucleotide BLAST search are given. 
The genes with the highest identity and the corresponding strains are named.  
Sequence  Identity  Strain and (putative) function  Accession number
SWB004 #1  512/690 (74%)  Frankia alni str. ACN14A, putative 6-methylsalicylic acid synthase  CT573213.2 
SWB004 #2  512/690 (74%)  Frankia alni str. ACN14A, putative 6-methylsalicylic acid synthase  CT573213.2 
SWB004 #3  512/690 (74%)  Frankia alni str. ACN14A, putative 6-methylsalicylic acid synthase  CT573213.2 
SWB004 #4  519/714 (72%)  Polyangium cellulosum So0157-2-KS1 beta-ketoacyl synthase gene  DQ359910.1 
SWB004 #5  512/714 (71%)  Polyangium cellulosum So0157-2-KS1 beta-ketoacyl synthase gene  DQ359910.1 
SWB004 #6  512/690 (74%)  Frankia alni str. ACN14A, putative 6-methylsalicylic acid synthase  CT573213.2 
SWB005 #1  567/638 (88%)  Enhygromyxa sp. SYM-1 gene for polyketide synthase  AB376534.1 
SWB005 #2  530/712 (74%)  Streptomyces abikoensis gene for PKS  AB430936.1 
SWB005 #3  541/706 (76%)  Polyangium cellulosum So ce26-KS7 beta-ketoacyl synthase gene  DQ359879.1 
SWB005 #4  530/712 (74%)  Streptomyces abikoensis gene for PKS  AB430936.1 
SWB006 #1  367/499 (73%)  Streptomyces sp. NRRL 11266 tetronomycin gene cluster  AB193609.1 
SWB006 #2  449/607 (73%)  Streptomyces sp. ID05-A0343, gene for PKS  AB431909.1 
SWB006 #3  350/474 (73%)  Actinoplanes sp. ID05-A0405, gene for PKS  AB432011.1 
SWB006 #4  511/694 (73%)  Streptomyces sp. ID05-A0343, gene for PKS  AB431909.1 
SWB006 #5  288/412 (69%)  Streptomyces noursei ATCC 11455, nystatin biosynthetic gene cluster  AF263912.1 
Extracts of all three bacterial isolates were evaluated for antimicrobial activity in agar diffusion 
assays. In the first tests (see experimental section), only the methanol extract of SWB005 showed 
activity against the Gram-positive test strain B. megaterium with an inhibition zone of 10 mm at a 
concentration of 250 µg. Testing the extracts against a broader bacterial spectrum, the methanol extract 
showed inhibitory activity towards methicillin resistant Staphylococcus aureus (MRSA), S. epidermidis, 
as well as against a coagulase-negative Staphylococcus sp. (Table 3). Furthermore an inhibitory 
activity towards MRSA was detectable in all fractions. It was found that the antibiotic activity of the 
SWB005 extract was strongly dependant on culture conditions, e.g., cultivation in marine broth medium 
revealed that SWB005 could grow in this complex medium, but the resulting extracts showed no activity. 
Table 3. Inhibition zones of the SWB005 extracts against bacterial strains in agar diffusion 
assay. The inhibition zone is given in millimeters (mm), the filter discs were 6 mm in 
diameter. Concentration of the extracts was 5 mg/mL; 40 µL were spotted on the discs.  
Strain\Extract  Dichloromethane Ethylacetate Acetone  Methanol
MRSA LT1334  13  14  11  8 
MRSA LT1338  10  10  8  8 
MRSE LT1324  -  -  m.i.  11 
CNS I-10925  -  -  -  m.i. 
Escherichia coli I-11276b  -  -  -  - 
Escherichia coli O-19592 -  -  -  - 
Klebsiella pneumoniae I-10910  -  -  -  - 
Pseudomonas aeruginosa 4991 -  -  -  - 
Pseudomonas aeruginosa I-10968 -  -  -  - 
Citrobacter freundii I-11090  - -  -  - Mar. Drugs 2010, 8  
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Table 3. Cont. 
Staphylococcus aureus I-11574  -  -  m.i.  9 
Staphylococcus aureus 5185  -  -  m.i.  9 
Stenotrophomonas maltophilia O-16451 -  -  -  - 
Stenotrophomonas maltophilia I-10717  -  -  -  m.i. 
Enterococcus I-11305b  -  -  -  9 
Enterococcus I-11054  -  -  m.i.  9 
Staphylococcus simulans 22  -  -  m.i.  21 
Micrococcus luteus ATCC 4658  -  -  10  18 
Staphylococcus epidermidis 25 -  -  -  13 
Staphylococcus aureus SG511  -  -  9  14 
MRSA: methicillin resistant Staphylococcus aureus; MRSE: methicillin resistant Staphylococcus epidermidis; 
CNS: coagulase-negative Staphylococcus sp.; -: not active; m.i.: minimal inhibition. 
In future work, the compounds responsible for this activity will be determined. In order to obtain 
sufficient biomass and production of the antibiotic compounds, cultivation conditions for this marine 
organism have to be further optimized, which will also allow further utilization of marine 
myxobacteria as an important source for natural compounds. 
3. Experimental Section  
3.1. Sample collection, isolation and bacterial strains 
The strains SWB004, SWB005 and SWB006 were isolated from sediment samples collected in 
2006–2009 from the beach area of Santa Barbara, U.S. (strain SWB005), Texel, Netherlands 
(SWB004) and Borkum, Germany (SWB006), respectively. Screening for myxobacteria was 
performed by putting the sample on an E. coli spot which was situated on artificial seawater (ASW, 
see below) agar. To inhibit the growth of fungi, cycloheximide was added to the agar. Incubation was 
performed at 30 °C. If lysis of the E. coli was observed, this sample was transferred to a new plate 
until an axenic culture could be obtained. The strain Enhygromyxa salina DSM 15201 was used in the 
studies as reference strain. 
3.2. Morphological and physiological characterization 
Morphology and fruiting body formation were observed on VY¼ [bakers yeast, 0.25%; 
CaCl2·2H2O, 1.36 g/L; vitamin B12, 0.5 µg/mL] agar plates incubated at 30 °C. For microscopy the 
cells were scraped from the agar plate and observed using a phase-contrast microscope (Olympus 
BX51). The physiological characterization of SWB004, SWB005 and SWB006 was in essence done as 
described for E. salina [6]. Lytic activity toward alginate, cellulose, chitin, starch and tween20 was 
determined on CY⅓ medium. Growth responses to different temperatures and salt concentrations were 
determined on VY¼ agar plates. For the determination of the cationic requirements CY⅓ + Na
+ agar 
was used as the basic medium [(g/L): Bacto Casitone (Difco), 1; Bacto Yeast Extract (Difco), 0.3; 
NaCl, 20; Bacto Agar (Difco), 15; (pH 7.3)]. The following cations (salts, g/L) were added to the basis 
medium: K
+, (KCl, 0.5); Ca
2+, (CaCl2·2H2O, 1.0); Mg
2+, (MgSO4·7H2O, 8.0); Ca
2+/Mg
2+, Mar. Drugs 2010, 8  
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(CaCl2·2H2O, 1.0; MgSO4·7H2O, 8.0); and K
+/Ca
2+/Mg
2+, (KCl, 0.5, CaCl2·2H2O, 1.0; MgSO4·7H2O, 
8.0). As artificial seawater for the media were used SWS [(g/L): ferric citrate, 0.01; MgSO4·7H2O, 8; 
CaCl2·2H2O, 1; KCl, 0.5; NaHCO3, 0.16; H3BO3, 0.02; KBr, 0.08; SrCl2·6H2O, 0.03;   
Di-natrium-glycerophosphate, 0.01] and ASW [(g/L): KCl, 0.66; KBr, 0.1; NaCl, 23.48; MgSO4·7H2O, 
10.61; CaCl2·2H2O, 1.47; SrCl2·6H2O, 0.04; NaSO4, 3.92; NaHCO3, 0.19; H3BO3, 0.03], respectively. 
The complex marine broth medium was obtained from Difco. 
3.3. Chemotaxonomy 
Fatty acid composition was analyzed using GC/MS. Therefore the cell pellet was vacuum-dried and 
dissolved in 1 mL methanolic HCl (1N) to generate fatty acid methyl esters (FAMEs). After 20–30 min 
incubation in an 80 °C water bath 1 mL 0.9% NaCl and 1 mL hexane were added. After solvent 
extraction, the organic phase was transferred into a new vial and dried. To test if there are any 
hydroxylated fatty acids present in the sample, a silylation step followed, which enabled a better detection 
of these FAMEs. Therefore 600 µL MSTFA (N-Methyl-N-(trimethylsilyl)-2,2,2-trifluoracetamid) was 
added to the sample and incubation was performed 20–30 min in an 80 °C water bath. Subsequently 
the samples were dried and resolved in 50 µl hexane. Fatty acid methyl esters were separated by GC-MS 
on an Agilent HP 6890 plus GC with mass selective detector 5973inert (Agilent Technologies, 
Böblingen, Germany), equipped with a 30 m HP-5MS 19091S-433 column (Agilent) using a 
temperature gradient starting at 150 °C, increased up to 280 °C at 10 °C/min (holding time 10.5 min), 
and decreased to 150 °C at 20 °C/min.  
3.4. DNA analysis 
Genomic DNA was isolated with the Promega DNA purification kit according to the 
manufacturer’s instructions. For the 16S rDNA analysis PCRs were performed with the primer pair pA 
(5´AGAGTTTGATCCTGGCTCAG3’) and pH (5’AAGGAGGTGATCCAGCCCCA3’). The resulting 
DNA fragments were gel-purified and subsequently sequenced by GATC, Constance (Germany). For 
the amplification of the ketosynthase part of the PKS genes the degenerated primer pair KSup 
(5’MGNGARGCNNWNSMNATGGAYCCNCARCANMG3’) and KSdn 
(5’GGRTCNCCNARNSWNGTNCCNGTNCCRTG3’) was used. The obtained PCR fragments were 
gel-purified and subsequently ligated into the cloning vector pGEM-T (Promega). Calciumchloride 
competent  E. coli XL1 Blue cells were transformed with the resulting plasmids and plated on 
ampicillin containing selection agar. Clones were randomly picked and plasmids were isolated using 
the Pure Yield Miniprep System kit (Promega). The inserts of these plasmids were sequenced by 
GATC, Constance (Germany). The sequences were analysed using nucleotide BLAST and   
ClustalW [22,23]. Phylogenetic trees were constructed with ClustalW. 
The DNA G + C contents were determined using HPLC [24]. The values are given in % and are the 
means of three independent analyses of the same DNA sample. The analysis was performed by the 
Belgium Co-ordinated Collections of Micro-organisms (BCCM
TM, Gent, Belgium). 
The accession numbers of the 16S rDNA sequence data for the strains SWB004, SWB005 and 
SWB006 are HM769727, HM769728 and HM769729, respectively. 
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3.5. Agar diffusion assay 
Cultivation of the strains was performed in 5-L-Erlenmeyer flasks, each containing 1 L of VY¼ 
medium with 2% amberlite XAD-16 (Fluka, Germany). The flasks were inoculated with a preculture 
from sheared agar plates and shaken on a rotary shaker (140 rpm) at 30 °C for 14 days. At the end of 
the cultivation, bacterial cells and adsorber resin were separated from the culture broth by 
centrifugation and extracted with acetone (1.5 L). 
After removal of the solvent, the residue was suspended in methanol 60% (50 mL) and extracted 
four times with dichloromethane (DCM; 60 mL). The DCM layers were combined and dried. 
Separation of this extract into four fractions was done by vacuum liquid column chromatography over 
Polygoprep 60-50 RP (Macherey-Nagel) by consecutively employing DCM, ethylacetate, acetone and 
methanol. 50 µL of the resulting fractions (concentration: 5 mg/mL) were dropped on a filter disc and 
put on the agar plates with the test organisms (namely Bacillus megaterium,  Chlorella fusca, 
Escherichia coli, Eurotium rubrum, Microbotryum violaceum and Mycotypha microspora). For the 
following agar diffusion assay with pathogenic bacteria, the suspension of bacterial strains was floated 
on Müller-Hinton-Agar. Filter discs with 40 µL extract (5 mg/mL) were put onto the agar plates and 
incubation was performed over night at 34 °C. The test strains were from the collection of the Institute 
of Medical Microbiology, Immunology and Parasitology (IMMIP). 
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